Vivek P. Jani MS , Joban Vaishnav MD , Soumya Vungarala MD , Virginia S. Hahn MD , Danielle Hopkins BS , Rishi Trivedi MD, PhD , Wendy Ying MD , David A. Kass MD , Dhananjay Vaidya MBBS, PhD , Kavita Sharma MD
{"title":"充血和低心输出量血流动力学表型驱动超重和肥胖HFpEF的结局。","authors":"Vivek P. Jani MS , Joban Vaishnav MD , Soumya Vungarala MD , Virginia S. Hahn MD , Danielle Hopkins BS , Rishi Trivedi MD, PhD , Wendy Ying MD , David A. Kass MD , Dhananjay Vaidya MBBS, PhD , Kavita Sharma MD","doi":"10.1016/j.jchf.2025.102586","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Hemodynamic assessment of congestion and perfusion in overweight and obese patients with heart failure with preserved ejection fraction (HFpEF), and the respective impact of hemodynamic phenotypes on clinical outcomes has been limited to date.</div></div><div><h3>Objectives</h3><div>The authors characterized predominantly overweight and obese HFpEF patients by hemodynamic assessment of congestion and perfusion status and correlated these hemodynamic phenotypes with clinical outcomes.</div></div><div><h3>Methods</h3><div>A total of 227 patients referred to the Johns Hopkins HFpEF Clinic meeting clinical criteria for HFpEF and with right heart catheterization assessment were included. Hemodynamic-based groups were assigned as follows: dry-warm (pulmonary capillary wedge pressure [PCWP] <15 mm Hg, cardiac index >2.2 L/min/m<sup>2</sup>), wet-warm (PCWP ≥15 mm Hg, cardiac index >2.2 L/min/m<sup>2</sup>), dry-cold (PCWP <15 mm Hg, cardiac index ≤2.2 L/min/m<sup>2</sup>), and wet-cold (PCWP ≥15 mm Hg, cardiac index ≤2.2 L/min/m<sup>2</sup>).</div></div><div><h3>Results</h3><div>Compared to “warm” profile patients, HFpEF subjects classified as “cold” profile (dry-cold + wet-cold) accounted for 34% of the cohort and were more likely to be older (cold: 68 ± 11 years vs warm: 62 ± 12 years; <em>P</em> = 0.002), male (cold: 51% vs warm 66%; <em>P</em> = 0.04), have atrial fibrillation (<em>P</em> = 0.0007), with higher N-terminal pro–B-type natriuretic peptide (<em>P</em> = 0.03), and higher pulmonary vascular resistance indices. Of the 4 hemodynamic groups, wet-cold patients had the highest N-terminal pro–B-type natriuretic peptide levels (469 pg/mL [Q1-Q3: 257-1,389 pg/mL]; overall <em>P =</em> 0.0001), highest rate of atrial fibrillation (54%, overall <em>P</em> = 0.001), and were more likely to be on beta-blocker therapy (68%; <em>P =</em> 0.05). Kaplan-Meier survival analysis (median follow-up time: 39 months) revealed that HFpEF patients with low cardiac perfusion (thermodilution method and Fick method) had worse mortality even after accounting for potential overcorrection from body mass index.</div></div><div><h3>Conclusions</h3><div>In a predominantly overweight and obese HFpEF cohort meeting standard diagnostic criteria for clinical HFpEF, 34% had a depressed cardiac index on hemodynamic testing. Hemodynamic assessment may identify an under-recognized low-output hemodynamic phenotype in HFpEF, which in combination with congestion, is associated with worse clinical outcomes.</div></div>","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 11","pages":"Article 102586"},"PeriodicalIF":11.8000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Congestion and Low Cardiac Output Hemodynamic Phenotype Drives Outcomes in Overweight and Obese HFpEF\",\"authors\":\"Vivek P. Jani MS , Joban Vaishnav MD , Soumya Vungarala MD , Virginia S. Hahn MD , Danielle Hopkins BS , Rishi Trivedi MD, PhD , Wendy Ying MD , David A. Kass MD , Dhananjay Vaidya MBBS, PhD , Kavita Sharma MD\",\"doi\":\"10.1016/j.jchf.2025.102586\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Hemodynamic assessment of congestion and perfusion in overweight and obese patients with heart failure with preserved ejection fraction (HFpEF), and the respective impact of hemodynamic phenotypes on clinical outcomes has been limited to date.</div></div><div><h3>Objectives</h3><div>The authors characterized predominantly overweight and obese HFpEF patients by hemodynamic assessment of congestion and perfusion status and correlated these hemodynamic phenotypes with clinical outcomes.</div></div><div><h3>Methods</h3><div>A total of 227 patients referred to the Johns Hopkins HFpEF Clinic meeting clinical criteria for HFpEF and with right heart catheterization assessment were included. Hemodynamic-based groups were assigned as follows: dry-warm (pulmonary capillary wedge pressure [PCWP] <15 mm Hg, cardiac index >2.2 L/min/m<sup>2</sup>), wet-warm (PCWP ≥15 mm Hg, cardiac index >2.2 L/min/m<sup>2</sup>), dry-cold (PCWP <15 mm Hg, cardiac index ≤2.2 L/min/m<sup>2</sup>), and wet-cold (PCWP ≥15 mm Hg, cardiac index ≤2.2 L/min/m<sup>2</sup>).</div></div><div><h3>Results</h3><div>Compared to “warm” profile patients, HFpEF subjects classified as “cold” profile (dry-cold + wet-cold) accounted for 34% of the cohort and were more likely to be older (cold: 68 ± 11 years vs warm: 62 ± 12 years; <em>P</em> = 0.002), male (cold: 51% vs warm 66%; <em>P</em> = 0.04), have atrial fibrillation (<em>P</em> = 0.0007), with higher N-terminal pro–B-type natriuretic peptide (<em>P</em> = 0.03), and higher pulmonary vascular resistance indices. Of the 4 hemodynamic groups, wet-cold patients had the highest N-terminal pro–B-type natriuretic peptide levels (469 pg/mL [Q1-Q3: 257-1,389 pg/mL]; overall <em>P =</em> 0.0001), highest rate of atrial fibrillation (54%, overall <em>P</em> = 0.001), and were more likely to be on beta-blocker therapy (68%; <em>P =</em> 0.05). Kaplan-Meier survival analysis (median follow-up time: 39 months) revealed that HFpEF patients with low cardiac perfusion (thermodilution method and Fick method) had worse mortality even after accounting for potential overcorrection from body mass index.</div></div><div><h3>Conclusions</h3><div>In a predominantly overweight and obese HFpEF cohort meeting standard diagnostic criteria for clinical HFpEF, 34% had a depressed cardiac index on hemodynamic testing. Hemodynamic assessment may identify an under-recognized low-output hemodynamic phenotype in HFpEF, which in combination with congestion, is associated with worse clinical outcomes.</div></div>\",\"PeriodicalId\":14687,\"journal\":{\"name\":\"JACC. Heart failure\",\"volume\":\"13 11\",\"pages\":\"Article 102586\"},\"PeriodicalIF\":11.8000,\"publicationDate\":\"2025-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC. Heart failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213177925005141\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Heart failure","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213177925005141","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Congestion and Low Cardiac Output Hemodynamic Phenotype Drives Outcomes in Overweight and Obese HFpEF
Background
Hemodynamic assessment of congestion and perfusion in overweight and obese patients with heart failure with preserved ejection fraction (HFpEF), and the respective impact of hemodynamic phenotypes on clinical outcomes has been limited to date.
Objectives
The authors characterized predominantly overweight and obese HFpEF patients by hemodynamic assessment of congestion and perfusion status and correlated these hemodynamic phenotypes with clinical outcomes.
Methods
A total of 227 patients referred to the Johns Hopkins HFpEF Clinic meeting clinical criteria for HFpEF and with right heart catheterization assessment were included. Hemodynamic-based groups were assigned as follows: dry-warm (pulmonary capillary wedge pressure [PCWP] <15 mm Hg, cardiac index >2.2 L/min/m2), wet-warm (PCWP ≥15 mm Hg, cardiac index >2.2 L/min/m2), dry-cold (PCWP <15 mm Hg, cardiac index ≤2.2 L/min/m2), and wet-cold (PCWP ≥15 mm Hg, cardiac index ≤2.2 L/min/m2).
Results
Compared to “warm” profile patients, HFpEF subjects classified as “cold” profile (dry-cold + wet-cold) accounted for 34% of the cohort and were more likely to be older (cold: 68 ± 11 years vs warm: 62 ± 12 years; P = 0.002), male (cold: 51% vs warm 66%; P = 0.04), have atrial fibrillation (P = 0.0007), with higher N-terminal pro–B-type natriuretic peptide (P = 0.03), and higher pulmonary vascular resistance indices. Of the 4 hemodynamic groups, wet-cold patients had the highest N-terminal pro–B-type natriuretic peptide levels (469 pg/mL [Q1-Q3: 257-1,389 pg/mL]; overall P = 0.0001), highest rate of atrial fibrillation (54%, overall P = 0.001), and were more likely to be on beta-blocker therapy (68%; P = 0.05). Kaplan-Meier survival analysis (median follow-up time: 39 months) revealed that HFpEF patients with low cardiac perfusion (thermodilution method and Fick method) had worse mortality even after accounting for potential overcorrection from body mass index.
Conclusions
In a predominantly overweight and obese HFpEF cohort meeting standard diagnostic criteria for clinical HFpEF, 34% had a depressed cardiac index on hemodynamic testing. Hemodynamic assessment may identify an under-recognized low-output hemodynamic phenotype in HFpEF, which in combination with congestion, is associated with worse clinical outcomes.
期刊介绍:
JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.